<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02139085</url>
  </required_header>
  <id_info>
    <org_study_id>IDPC 2014</org_study_id>
    <nct_id>NCT02139085</nct_id>
  </id_info>
  <brief_title>Great Saphenous Vein Electrocoagulation</brief_title>
  <official_title>A Prospective Double Blind Randomized Controlled Trial Of Electrocoagulation Versus Radiofrequency Treatment Of The Great Saphenous Vein In Patients With Varicose Veins.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Dante Pazzanese de Cardiologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Dante Pazzanese de Cardiologia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Lower extremity Chronic Venous Insufficiency is a prevalent disease that
      adversely affects an individual's Quality of Life. Varicose vein endovenous radiofrequency
      treatment have a lower risk of iatrogenic injuries and offer faster return to work
      activities, when compared with open surgical techniques. Endovenous electrocoagulation can
      selectively and safely cause Great Saphenous Vein (GSV) wall necrosis but its clinical
      results has never been studied before.

      Objective: The objective of this study is to compare Great Saphenous Vein electrocoagulation
      and radio frequency (RF) endovascular varicose vein treatment clinical results and quality of
      life improvement in a prospective double blind randomized controlled clinical trial.

      Methods: Consecutive patients with varicose veins and primary GSV reflux will be randomized
      to Electrocoagulation or Radiofrequency endovenous treatment. The primary outcome measure
      will be GSV occlusion rate at 3 and 6 months after treatment verified by Duplex Scanning
      (DS). Secondary outcome measures will be pain visual analogue scale (VAS), bruising,
      neuropathy and vein thrombosis frequency in the immediate postoperative period (1 week); and
      Clinical Etiology Anatomy and Pathophysiology (CEAP) classification ,Venous Clinical Severity
      Scale (VCSS), and Aberdeen Varicose Vein Questionnaire (AVVQ), obtained preoperatively, at 3
      and 6 months postoperatively. For statistical analysis, we will use the Student's t test, the
      Mann-Whitney test and Pearson's correlation, considering positive statistical significance
      when level of p &lt;0.05.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients included in the study will be preoperatively examined to evaluate the severity
      of venous disease, using the CEAP classification, VCSS and AVVQ. They will undergo venous DS
      with the aim of investigating GSV insufficiency, its caliber and depth and presence of
      previous thrombophlebitis.

      Patients will be randomized on the day of surgery with an electronic table of random numbers:

      Group 1:Electrocoagulation treatment. Group 2: Radiofrequency treatment.

      Patients and outcomes assessor will be blinded to the group of endovenous treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GSV occlusion</measure>
    <time_frame>3 months</time_frame>
    <description>GSV occlusion verified by blinded DS operator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>GSV occlusion</measure>
    <time_frame>6 months</time_frame>
    <description>GSV occlusion verified by blinded DS operator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain VAS</measure>
    <time_frame>1 week</time_frame>
    <description>Pain VAS by blinded Outcomes Assessor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative bruising</measure>
    <time_frame>1 week</time_frame>
    <description>The bruised area traced manually, and the surface area estimated by placing the tracing on a square chart.
Assessment by blinded Outcomes Assessor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative sensory abnormality</measure>
    <time_frame>1 week</time_frame>
    <description>Overall incidence of postoperative sensory abnormality: Numbness or decreased sensation, paresthesia and dysesthesia.
Assessment by blinded Outcomes Assessor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Venous Clinical Severity Score (VCSS)</measure>
    <time_frame>6 months</time_frame>
    <description>Difference from baseline. Assessment by blinded Outcomes Assessor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aberdeen Varicose Vein Questionnaire (AVVQ)</measure>
    <time_frame>6 months</time_frame>
    <description>Difference from baseline. Assessment by blinded Outcomes Assessor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep Venous Thrombosis (DVT)</measure>
    <time_frame>1 week</time_frame>
    <description>Presence of DVT verified by blinded DS operator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Etiology Anatomy Pathophysiology (CEAP)</measure>
    <time_frame>6 months</time_frame>
    <description>Difference from baseline. Assessment by blinded Outcomes Assessor.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Venous Disease</condition>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>GSV Electrocoagulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GSV Electrocoagulation Source: Electrosurgical Generator(FX-Valley Lab; USA) Energy: 60 Watts x 10 seconds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GSV Radiofrequency</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GSV Radiofrequency Source: Closure FAST(Covidien, USA) Energy: 60 Joules / cm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GSV Electrocoagulation</intervention_name>
    <description>The energy source will be the Electrosurgical Generator (FX-Valley Lab; USA) and the GSV thermo ablation will be performed with 60 Watts per 10 seconds. The catheter and electrocoagulation device head will be pulled back in increments of 2 cm also to overlap the treatment sites.</description>
    <arm_group_label>GSV Electrocoagulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GSV Radiofrequency</intervention_name>
    <description>The second generation RF device (Closure FAST; Covidien, USA) will be used. The treatment component of the device is 7 cm in length and works with a segmental pullback protocol. Once the catheter is in position, activation of the generator delivers 20- seconds cycles of energy to the catheter tip, which heats the vein wall to 120 o C.</description>
    <arm_group_label>GSV Radiofrequency</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic varicose veins of the lower limbs and partial or total failure (venous
             reflux) of the GSV

        Exclusion Criteria:

          -  Previous varicose vein surgery with removal of the GSV

          -  Pregnant women

          -  Patients in use of anticoagulants

          -  Known thrombophilia

          -  Presence of saphenous vein tortuosity and/or depth less then 7 mm from the skin

          -  GSV diameter &lt; 5mm and &gt; 12 mm

          -  Previous deep vein thrombosis

          -  Peripheral arterial disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabio H Rossi, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dante Pazzanese</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabio H Rossi, PHD</last_name>
    <phone>551142276668</phone>
    <email>vascular369@me.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nilo M Izukawa, PHD</last_name>
    <phone>551150856000</phone>
    <phone_ext>4122</phone_ext>
    <email>nilosmk.ops@terra.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese de Cardilogia</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>SP</state>
        <zip>04012-909</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio H Rossi, PHD</last_name>
      <phone>551150856000</phone>
      <phone_ext>4120</phone_ext>
      <email>vascular369@me.com</email>
    </contact>
    <investigator>
      <last_name>Fabio H Rossi, HD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.jvsvenous.org/article/S2213-333X(13)00253-9/abstract</url>
    <description>Article in Press</description>
  </link>
  <link>
    <url>http://www.scielo.br/pdf/acb/v26n5/a01v26n5.pdf</url>
    <description>free article</description>
  </link>
  <link>
    <url>http://www.scielo.br/pdf/jvb/v11n4/09.pdf</url>
    <description>free article</description>
  </link>
  <reference>
    <citation>Rossi FH, Beteli CB, Zamorano MB, Silva LM. Immediate effects of endovascular electrocauterization in lower limb varicose veins. J Vasc Bras 11(3): 305-309, 2012.</citation>
  </reference>
  <reference>
    <citation>Rossi FH, Izukawa NM, Silva DG, Chen J, Prakasan AK, Zamorano MM, Silva LM. Effects of electrocautery to provoke endovascular thermal injury. Acta Cir Bras. 2011 Oct;26(5):329-32.</citation>
    <PMID>21952653</PMID>
  </reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2014</study_first_submitted>
  <study_first_submitted_qc>May 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2014</study_first_posted>
  <last_update_submitted>August 6, 2014</last_update_submitted>
  <last_update_submitted_qc>August 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Dante Pazzanese de Cardiologia</investigator_affiliation>
    <investigator_full_name>Fabio H Rossi</investigator_full_name>
    <investigator_title>vascular surgeon PhD</investigator_title>
  </responsible_party>
  <keyword>varicose veins</keyword>
  <keyword>catheter ablation</keyword>
  <keyword>Catheter Ablation, Electrical</keyword>
  <keyword>Catheter Ablation, Radiofrequency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

